Jaipur Bio-Tech Pvt. Ltd - Charges

Every charge - open or closed - that lenders have registered against Jaipur Bio-Tech Pvt. Ltd, with the most recent activity at the top.

1994-01-18 Jaipur, Rajasthan Active Unlisted Active Compliant
Share
Connect MCP
JB Jaipur Bio-Tech Pvt. Ltd
Open charges
0
0.00
Closed charges
3
79.50 Lakh
Total
3
79.50 Lakh
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Small Industries Development Bank Of Ind… 3 79.50 Lakh
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
10142104 Small Industries Development Bank Of India 21 Jan 2009 - 13 Jan 2011 26.00 Lakh Closed
10142101 Small Industries Development Bank Of India 09 Jan 2009 - 13 Jan 2011 13.50 Lakh Closed
10055830 Small Industries Development Bank Of India 20 Jun 2007 - 13 Jan 2011 40.00 Lakh Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Jaipur Bio-Tech Pvt. Ltd?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Jaipur Bio-Tech Pvt. Ltd (CIN: U01122RJ1994PTC007961). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Jaipur Bio-Tech Pvt. Ltd.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.